Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Hemasphere|January 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC)Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryBlanca Espinet, Ana Ferrer, Beatriz Bellosillo, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|October 6, 2023
Characteristics of digoxin toxicity attended in Spanish emergency departments according to type of poisoning and administration of digoxin antibodies: the DIGITOX studyAugust Supervía, Andrea Martínez Baladrón, Francisca Córdoba, et al.
Blood|May 19, 2010
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma GroupMarta Salido, Cristina Baró, David Oscier, et al.
Genes, Chromosomes & Cancer|June 12, 2014
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcomeAnna Puiggros, Marta Venturas, Marta Salido, et al.
The American Journal of Emergency Medicine|May 7, 2024
Seven- and thirty-day mortality in digoxin poisoning: Results from the DIGITOX studyAugust Supervía, Antonio F Caballero-Bermejo, Jordi Puiguriguer, et al.
Oncotarget|November 9, 2016
Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrationsGonzalo Blanco, Anna Puiggros, Panagiotis Baliakas, et al.
Blood|May 18, 2018
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcomeGuillem Clot, Pedro Jares, Eva Giné, et al.
Oncotarget|September 15, 2017
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletionsAnna Puiggros, Rosa Collado, Maria José Calasanz, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Autoantibodies are associated with worse outcomes in MASLDAnna Soria, Alba Díaz, Paula Iruzubieta, et al.
Pageof 10